Cargando…

Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms

One of the most prevalent cardiovascular problems linked with type 2 diabetes mellitus (T2DM) is diabetic cardiomyopathy (DCM). DCM is associated with myocardial oxidative stress, inflammation, apoptosis, suppressed autophagy, extracellular matrix remodeling, and fibrosis. The current study aims to...

Descripción completa

Detalles Bibliográficos
Autores principales: Eldesoqui, Mamdouh, Eldken, Zienab Helmy, Mostafa, Sally Abdallah, Al-Serwi, Rasha Hamed, El-Sherbiny, Mohamed, Elsherbiny, Nehal, Mohammedsaleh, Zuhair M., Sakr, Noha Hammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315877/
https://www.ncbi.nlm.nih.gov/pubmed/35888760
http://dx.doi.org/10.3390/metabo12070635
_version_ 1784754670246297600
author Eldesoqui, Mamdouh
Eldken, Zienab Helmy
Mostafa, Sally Abdallah
Al-Serwi, Rasha Hamed
El-Sherbiny, Mohamed
Elsherbiny, Nehal
Mohammedsaleh, Zuhair M.
Sakr, Noha Hammad
author_facet Eldesoqui, Mamdouh
Eldken, Zienab Helmy
Mostafa, Sally Abdallah
Al-Serwi, Rasha Hamed
El-Sherbiny, Mohamed
Elsherbiny, Nehal
Mohammedsaleh, Zuhair M.
Sakr, Noha Hammad
author_sort Eldesoqui, Mamdouh
collection PubMed
description One of the most prevalent cardiovascular problems linked with type 2 diabetes mellitus (T2DM) is diabetic cardiomyopathy (DCM). DCM is associated with myocardial oxidative stress, inflammation, apoptosis, suppressed autophagy, extracellular matrix remodeling, and fibrosis. The current study aims to investigate the protective effect of sodium-glucose transport 2 inhibitor (SGLT2i) dapagliflozin and/or exercise on DCM. Thirty adult male Sprague Dawley rats are used. T2DM is induced by a 6-week high-fat diet (HFD) followed by a single intraperitoneal (IP) injection of 35 mg/kg streptozotocin (STZ). Rats are divided into five groups, control, diabetic (DM), DM + swimming, DM + dapagliflozin, and DM + dapagliflozin and swimming. Serum glucose, insulin, insulin resistance (HOMA-IR), and cardiac enzymes (CK-MB and lactate dehydrogenase (LDH) are measured. Heart specimens are used for evaluation of cellular oxidative stress markers malondialdehyde (MDA), antioxidant enzymes, glutathione (GSH), and catalase (CAT), as well as mRNA expression of TGF-β, MMP9, IL-1β, and TNF-α. Stained sections with haematoxylin and eosin (H & E) and Masson trichrome are used for histopathological evaluation and detection of fibrosis, respectively. Immunohistochemical staining for apoptosis (caspase-3), and autophagy (LC3) are also carried out. The combinations of SGLT2i and exercise exhibited the most significant cardioprotective effect. It improved diabetic-induced histopathological alterations in the myocardium and attenuated the elevation of serum blood glucose, CK-MB, LDH, myocardial MDA, and mRNA expression of TNF-α, IL-1β, TGF-β, MMP9, and the immune expression of caspase-3. Moreover, this combination increased the serum insulin, myocardial antioxidants GSH and CAT, and increase the immune expression of the LC-3. In conclusion, a combination of SGLT2i and exercise exerted a better antioxidant, anti-inflammatory, and antifibrotic effect in DCM. Moreover, the combination enhances the autophagic capacity of the heart.
format Online
Article
Text
id pubmed-9315877
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93158772022-07-27 Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms Eldesoqui, Mamdouh Eldken, Zienab Helmy Mostafa, Sally Abdallah Al-Serwi, Rasha Hamed El-Sherbiny, Mohamed Elsherbiny, Nehal Mohammedsaleh, Zuhair M. Sakr, Noha Hammad Metabolites Article One of the most prevalent cardiovascular problems linked with type 2 diabetes mellitus (T2DM) is diabetic cardiomyopathy (DCM). DCM is associated with myocardial oxidative stress, inflammation, apoptosis, suppressed autophagy, extracellular matrix remodeling, and fibrosis. The current study aims to investigate the protective effect of sodium-glucose transport 2 inhibitor (SGLT2i) dapagliflozin and/or exercise on DCM. Thirty adult male Sprague Dawley rats are used. T2DM is induced by a 6-week high-fat diet (HFD) followed by a single intraperitoneal (IP) injection of 35 mg/kg streptozotocin (STZ). Rats are divided into five groups, control, diabetic (DM), DM + swimming, DM + dapagliflozin, and DM + dapagliflozin and swimming. Serum glucose, insulin, insulin resistance (HOMA-IR), and cardiac enzymes (CK-MB and lactate dehydrogenase (LDH) are measured. Heart specimens are used for evaluation of cellular oxidative stress markers malondialdehyde (MDA), antioxidant enzymes, glutathione (GSH), and catalase (CAT), as well as mRNA expression of TGF-β, MMP9, IL-1β, and TNF-α. Stained sections with haematoxylin and eosin (H & E) and Masson trichrome are used for histopathological evaluation and detection of fibrosis, respectively. Immunohistochemical staining for apoptosis (caspase-3), and autophagy (LC3) are also carried out. The combinations of SGLT2i and exercise exhibited the most significant cardioprotective effect. It improved diabetic-induced histopathological alterations in the myocardium and attenuated the elevation of serum blood glucose, CK-MB, LDH, myocardial MDA, and mRNA expression of TNF-α, IL-1β, TGF-β, MMP9, and the immune expression of caspase-3. Moreover, this combination increased the serum insulin, myocardial antioxidants GSH and CAT, and increase the immune expression of the LC-3. In conclusion, a combination of SGLT2i and exercise exerted a better antioxidant, anti-inflammatory, and antifibrotic effect in DCM. Moreover, the combination enhances the autophagic capacity of the heart. MDPI 2022-07-11 /pmc/articles/PMC9315877/ /pubmed/35888760 http://dx.doi.org/10.3390/metabo12070635 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Eldesoqui, Mamdouh
Eldken, Zienab Helmy
Mostafa, Sally Abdallah
Al-Serwi, Rasha Hamed
El-Sherbiny, Mohamed
Elsherbiny, Nehal
Mohammedsaleh, Zuhair M.
Sakr, Noha Hammad
Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms
title Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms
title_full Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms
title_fullStr Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms
title_full_unstemmed Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms
title_short Exercise Augments the Effect of SGLT2 Inhibitor Dapagliflozin on Experimentally Induced Diabetic Cardiomyopathy, Possible Underlying Mechanisms
title_sort exercise augments the effect of sglt2 inhibitor dapagliflozin on experimentally induced diabetic cardiomyopathy, possible underlying mechanisms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315877/
https://www.ncbi.nlm.nih.gov/pubmed/35888760
http://dx.doi.org/10.3390/metabo12070635
work_keys_str_mv AT eldesoquimamdouh exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms
AT eldkenzienabhelmy exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms
AT mostafasallyabdallah exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms
AT alserwirashahamed exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms
AT elsherbinymohamed exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms
AT elsherbinynehal exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms
AT mohammedsalehzuhairm exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms
AT sakrnohahammad exerciseaugmentstheeffectofsglt2inhibitordapagliflozinonexperimentallyinduceddiabeticcardiomyopathypossibleunderlyingmechanisms